Change of Company Secretary, Issue of Equity

RNS Number : 3303G
Craven House Capital PLC
22 July 2019
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Craven House Capital plc

 

("Craven House" or the "Company")

 

Change of Company Secretary, Issue of Equity

 

 

Craven House Capital (AIM:CRV) announces the appointment of Ms. Tamra Spink as Company Secretary. Her predecessor, Mr. Brian Winters has stepped down from the role with effect from today.

 

The Company has allotted 14,400 ordinary shares of $1.00 in the capital of the Company ("Ordinary Shares") at a price of $12.50 per share to Mr. Brian Winters as settlement for company secretarial services provided by him since August 2016.

 

Application will be made for the admission to trading on AIM ("Admission") for the 14,400 new Ordinary Shares.  The new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares of the Company.  Admission is expected at 8.00 a.m. on or around 26 July 2019.

 

Total Voting Rights

 

Following Admission, the Company's issued share capital will comprise 2,513,438 Ordinary Shares which may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.  The Company does not hold any shares in treasury.

 

 

~ Ends ~

 

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel:   0203 286 8130

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.Sparkadvisorypartners.com

 

Tel:   0203 368 3550

 

 

About Craven House Capital:

 

The Company's Investing Policy is to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets globally in any geographic jurisdiction. The company will invest in both developed and developing markets providing long term patient capital and is often involved in special situations, restructuring, expansion and turn around investments in crisis and transitioning economies.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 Mr Brian Winters

2

Reason for the notification

a)

Position/status

Company Secretary

b)

Initial notification / Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Craven House Capital Plc

b)

Legal Entity Identifier

 2138008MJUBUX6WX9B72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of $1.00 each

 

 

 

GB00BD4FQ360

b)

Nature of the transaction

Issue of shares as part of salary

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

$12.50

14,400

 

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 N/A single transaction

 

f)

Date of the transaction

 22 July 2019

g)

Place of the transaction

London Stock Exchange, AIM

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFEEDFIFFIA
UK 100

Latest directors dealings